Meet our
Scientific Advisory Board

In April 2021 Cindy Bell retired from Genome Canada where she worked since August 2000. From 2000-2008 she held the position of Vice-President, Genomics Programs in which she was responsible for providing policy and strategic advice on scientific and other aspects of Genome Canada’s programs. This included overseeing and managing the peer review process used to establish the research programs of Genome Canada.

Since 2008, in her role as Executive Vice-President, Corporate Development she provided leadership in the development and implementation of strategic initiatives, partnerships and approaches to enhance Genome Canada’s business model and secure funding to support genomics research in Canada. From July to December 2015 she was Interim President and CEO of Genome Canada.

From 1994 to 2000 Dr. Bell was a Deputy Director in Programs Branch at the Medical Research Council of Canada (now the Canadian Institutes of Health Research). At MRC she managed a number of research programs and was involved in policy development and implementation.

From 1986 to 1994, Dr. Bell was a researcher at the University of California, Riverside. Her research focused on investigating the basic defect in the genetic disease, Cystic Fibrosis. She obtained her Ph.D. in Genetics from McGill University in 1986.